(Date:11/30/2009)...ATO, Calif., Nov. 30 Bio...ed today that the Food and Drug Administration (FD...minopyridine (3,4-DAP), amifampridine phosphate, f...henic Syndrome (LEMS). 3,4-DAP has previously rec...n October 2009, the Committee for Medicinal Produc...
(Date:11/30/2009)... , LONDON, November 30 Apa...was named Europe,s fastest growing,Biotech/Pharmac...e Deloitte,2009 Technology Fast 500 for EMEA (Euro...l ranking is based on a companies, five-year reven...f 8,318% over this period. This,achievement places...
(Date:11/27/2009)... PARIS, November 27 Sta...rket Oralair(R) in both adults and children,throug...st country where,Oralair(R) has been marketed, was... is now registered in Austria, Belgium, Bulgaria, ...ny, Greece, Hungary, Ireland, Italy,Latvia, Lithu...
(Date:11/25/2009)... Ambassador to Speak at Economic Club o...a (Vocus) November 25, 2009 -- Ambassador to Speak...Appia, French Ambassador for International Investm...Agency ,To view a biography of David Appia go to ...ppia is available to meet with press to discuss re...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3French Ambassador for International Investment to Visit Toronto December 11 2... Increasing Case Volumes Drive 78 Percent Revenue ...o the Prior Year Period , , ALISO VIEJO, Calif., ...emier anatomic pathology and molecular testing ser...the pharmaceutical industry, today reported prelim... year ended December 31, 2008. Financial results ...
...arch 11 XTL Biopharmaceuticals Ltd. (Nasdaq: XT...nary General Meetings ("EGMs") were postponed for ...ation due to the absence of a quorum. The postpone... Kiryat Weizmann Science Park, Rehovot, Israel 761... 18, 2009. , , Any proxy votes received at any ti...
...H, Switzerland, March 11 Simbionix,the world,s le... VirtaMed, a,Swiss medical engineering company, an...mbionix will exclusively distribute, market, and p...ed virtual reality hysteroscopy simulator. , S...ors for minimal,invasive surgery. "This new agreem...
Other Biology Technology:Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 2Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 3Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 4Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 5Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 6Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 7Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 8Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 9Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 10Clarient Reports Strong Revenue Increase for Fourth Quarter and Full-Year 2008 11Simbionix Increases Product Offerings for OB/GYN Physicians 2Rabbit Anti-MD-2 (IN) Polyclonal Antibody, Unconjugated from AnaSpec
Anti-MPM-2, phospho-Ser / Thr-Pro (Mitotic protein monoclonal #2) Antibody, Agarose Conjugated from Upstate
Goat Anti-Human Bcl-2, phospho (Thr74) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Calcium Channel alpha 2 delta-2 Monoclonal Antibody, Unconjugated, Clone 42 from BD Biosciences Pharmingen
Biology Products: